The Silicon Review
Medical advancements have been achieved through the collective efforts of science and technology to develop treatment for patients most in need.Delivering new medicines to patients can be a long and challenging task, requiring a flawless investigative process that entails several stages of research. Ensuringthat new medicines are safe, effective and can make a real difference to patients’ lives is very difficult. But AbbVie, a new kind of enterprise—a biopharmaceutical company, blends the stability, global scale, resources and commercial capabilities of a pharmaceutical company with the focus and culture of a biotech. Today, its employees around the world focus on delivering transformational medicines and therapies that offer significant patient benefits.
AbbVie’semployees are scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe. It comes up with new approaches to addressing today’s health issues—from life-threatening illness to chronic conditions.
It targets specific difficult-to-cure diseases where it can leverage its core R&D expertise to advance science. It is constantly working to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself. AbbVie sees a future full of possibility, where health is in reach and patient lives are improved.
Principles Make the Foundation
AbbVie’s identity is shaped by the work it does - producing innovative medicines, continually investing in its pipeline, and giving back to create healthier, more vibrant communities. Most of all, this identity has been shaped by the beliefs it shares that have emerged organically since AbbVie began.
Its purpose is profound, and its path is clear. It embraces the responsibility of making a remarkable impact on people's lives through the innovative medicines and solutions it creates together. This is driven by its compassion for people, commitment to innovation and inclusion, service to the community, and uncompromising integrity at the heart of everything it does.
Operating as one AbbVie team, it cares deeply for its patients, their families, its employees, and its communities. It strives to always do the right thing, pursuing the highest standards in quality, compliance, safety, and performance. In everything it does, it invests and innovates relentlessly to tackle unmet needs, creating new medicines and healthcare approaches for a healthier world.
Globally, its employees embrace diverse backgrounds and perspectives and treat everyone equally, with dignity and respect, allowing us all to achieve its best. It proudly does its part to serve and support its communities and protect the environment, making a lasting impact that's felt within healthcare and beyond.What it does isn't easy, but it perseveres because what it achieves inspires hope and transforms lives—every single day.
Principles in focus
Transforming lives:The company inspires hope and transform lives every day. It makes decisions based on its deep caring and compassion for people, delivering a lasting impact to its patients, their families, its employees and the community.
Acting with integrity:It strives to always do the right thing. With uncompromising integrity at the heart of everything it does, it pursues the highest standards in quality, compliance, safety and performance.
Driving innovation:It innovates relentlessly in everything it does to tackle unmet needs. It invests in the discovery and development of new medicines and healthcare approaches for a healthier world.
Embracing diversity & inclusion:The company treats everyone equally, with dignity and respect. Around the world, its employees embrace diverse backgrounds and perspectives which allow it to achieve its best.
Serving the community:The company is are proud to serve and support the community and do its part to protect the environment. It makes a remarkable impact that's felt within healthcare and beyond.
Meet the Expert
Richard A. Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company that employs approximately 47,000 people worldwide and markets medicines in more than 175+ countries.
Prior to AbbVie’s separation from Abbott in January 2013, Mr. Gonzalez was a 30-year Abbott veteran. He served as President and Chief Operating Officer of Abbott before briefly retiring in 2007. He also held various senior leadership positions in Abbott’s medical products businesses, including President and Chief Operating Officer of the Medical Products Group; Senior Vice President and President of the former Hospital Products Division; Vice President and President of the Health Systems Division; and Divisional Vice President and General Manager for Diagnostics Operations in the United States and Canada.
Mr. Gonzalez has been a long-standing leader in the greater-Chicago community. Currently, he is a member of the Commercial Club of Chicago and represents AbbVie on their Civic Committee.